Effect of Panchakarma (Ayurvedic therapeutic procedures) on Metabolic and Immunological markers in Swastha individuals

A prospective, assessor blind, open, parallel group study to observe the effects of Panchakarma (Ayurvedic therapeutic procedures)on selected metabolic and immunological markers in Healthy individuals

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2012/09/002982

Enrollment

Registered

2012-09-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Panchakarma (Ayurvedic therapeutic procedures:Vaman (Induced emesis), Virechan (Induced purgation), Anuvasan Basti (enemas with medicated oils), Asthapan Basti (enemas with plant decoct

Eligibility

Inclusion criteria

Inclusion criteria: 1. Apparently healthy individuals of either sex in the age group between 18 and 50 years. (Health will be defined as absence of any ailment at the time of recruitment and no evidence of any major illness for last six months) 2. Volunteer scoring equal to or more than 9 in or more Dhatusamya scoring system 3. Volunteer is ready to abide by trial procedures and to give informed consent

Exclusion criteria

Exclusion criteria: 1.Suffering from any neurological or psychiatric disorder 2.Has history of smoking or chronic alcohol intake. 3.Has participated in any investigational study 4 weeks prior to the enrolment in the study. 4.Has history of Panchakarma Vyapad (unwanted effects/ Complications). 5.Has history of immuno-deficient condition, including human immunodeficiency virus (HIV) infection 6.A family history of congenital or hereditary immunodeficiency 7.Has history of chronic infection with hepatitis B virus (HBs Ag positive) or with hepatitis C virus (anti-HCV positive) 8.Major congenital defects or serious chronic illness 9.Acute or chronic, clinically significant pulmonary, cardiovascular, hepatic, or renal functional abnormality, as determined by medical history, physical examination or laboratory screening tests, which in the opinion of the investigator, might interfere with the study objectives 10.Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
1. Changes in metabolic and immunological status of the Volunteer 2. Improvement in the Quality of life assessment will be done by using standard Health, Wellness and Quality of life questionnaire Timepoint: 0 day, immediately after completion of procedures and 90 days after completion of procedures	—

Secondary

Measure	Time frame
2. Improvement in the Quality of life assessment will be done by using standard Health, Wellness and Quality of life questionnaire Timepoint: 0 day, immediately after completion of procedures and 90 days after completion of procedures	—

Countries

India

Contacts

Public ContactDr Urmila Thatte

Seth GS Medical College and KEM Hospital

urmilathatte@gmail.com02224133767

Outcome results